- Home
- APLS vs NVG Comparison
APLS vs NVG Comparison
Compare APLS & NVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APLS | NVG |
|---|---|---|
| Founded | 2009 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.7B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | APLS | NVG |
|---|---|---|
| Price | $23.62 | $12.70 |
| Analyst Decision | Buy | |
| Analyst Count | 19 | 0 |
| Target Price | ★ $33.11 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 568.8K |
| Earning Date | 10-30-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.65% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $1,016,397,000.00 | N/A |
| Revenue This Year | $29.00 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $65.98 | ★ N/A |
| Revenue Growth | ★ 42.11 | N/A |
| 52 Week Low | $16.10 | $9.68 |
| 52 Week High | $35.72 | $12.21 |
Technical Indicators
Market Signals| Indicator | APLS | NVG |
|---|---|---|
| Relative Strength Index (RSI) | 62.06 | 62.58 |
| Support Level | $20.51 | $12.46 |
| Resistance Level | $21.72 | $12.68 |
| Average True Range (ATR) | 0.81 | 0.08 |
| MACD | 0.51 | 0.00 |
| Stochastic Oscillator | 92.66 | 92.59 |
Price Performance
Historical ComparisonAbout APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About NVG Nuveen AMT-Free Municipal Credit Income Fund
Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax and federal alternative minimum tax applicable to individuals and enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the investment adviser believes are underrated or undervalued or represent undervalued municipal market sectors.